AGP Picks
View all

Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

Press releases published on October 27, 2026

Helus Pharma Announces Co-Founders’ Transition from Executive Leadership as Company Advances Toward Next Stage of Development
Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
Humanitas Global Health Announces Launch and LSU DeepDrug License Agreement at AAPS PharmSci 360
OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly
Bexorg Appoints Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors
Actuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering
fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform
Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference
Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update
Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases
Vertero Completes Patient Enrollment in Phase 1b Clinical Study of VT-5006 – an Investigational Treatment for Parkinson’s Disease
Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
InflaRx Announces November Investor Events

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Channel of Togo

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.